Pra-ornsuda Sukrakanchana

Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: insights from the NeoAMR network

Grace Li, Julia Bielicki, ASM Nawshad Uddin Ahmed et al. · Archives of Disease in Childhood · 2019 · 119 citations · Full text

Medicine, Microbiology, Pediatrics +15

Urine Tenofovir Concentrations Correlate With Plasma and Relate to Tenofovir Disoproxil Fumarate Adherence: A Randomized, Directly Observed Pharmacokinetic Trial (TARGET Study)

Paul K. Drain, Rachel W. Kubiak, Oraphan Siriprakaisil et al. · Clinical Infectious Diseases · 2019 · 37 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +16

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

Pauline Amuge, Abbas Lugemwa, Ben Wynne et al. · The Lancet HIV · 2022 · 31 citations · Full text

Pharmacy, Infectious Diseases, Pediatrics +15

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial

Lameck Chinula, Lauren Ziemba, Sean S. Brummel et al. · The Lancet HIV · 2023 · 29 citations · Full text

Medicine, Maternal Health, Obstetrics +16

A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study

Tim R. Cressey, Oraphan Siriprakaisil, Virat Klinbuayaem et al. · BMC Infectious Diseases · 2017 · 27 citations · Full text

Public Health, Clinical Pharmacokinetics, Pharmacology +16